(19)
(11) EP 1 259 241 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
06.09.2006 Bulletin 2006/36

(45) Mention of the grant of the patent:
05.07.2006 Bulletin 2006/27

(21) Application number: 00982786.6

(22) Date of filing: 14.12.2000
(51) International Patent Classification (IPC): 
A61K 31/46(2006.01)
 A61P 25/08(2006.01)
(86) International application number:
PCT/BR2000/000137
(87) International publication number:
WO 2001/043745 (21.06.2001 Gazette 2001/25)

(54)

THE USE OF SCOPOLAMINE SALTS

ANWENDUNG VON SCOPOLAMINSALZEN

UTILISATION DE SELS DE SCOPOLAMINE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 17.12.1999 BR 9906220

(43) Date of publication of application:
27.11.2002 Bulletin 2002/48

(73) Proprietor: Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP
Alto da Lapa, 05468901 São Paulo, SP (BR)

(72) Inventors:
  • DE MORAES MELLO, Luiz, Eugênio, Aráujo
    CEP-05502-060 Sao Paulo, SP (BR)
  • GONCALVES MASSANT, Christina
    Sao Paulo, SP (BR)
  • KASTROPIL BENASSI, Simone
    Sao Paulo, SP (BR)

(74) Representative: Bongiovanni, Simone et al
Studio Torta S.r.l Via Viotti, 9
10121 Torino
10121 Torino (IT)


(56) References cited: : 
   
  • DATABASE WPI Week 199508, Derwent Publications Ltd., London, GB; AN 1995-255471, XP002956012 & CN 1 089 485 A (ZHAO Z) 20 July 1994
  • DATABASE WPI Week 199534, Derwent Publications Ltd., London, GB; AN 1995-255461, XP002956013 & CN 1 089 473 A (ZHAO Z) 20 July 1994
  • DATABASE CA [Online] LYETH B.G. ET AL.: 'Effects of scopolamine treatment on long-term behavioral deficits following concussive brain unjury to the rat', XP002942614 Database accession no. 109:32080 & BRAIN RES. vol. 452, no. 1-2, 1988, pages 39 - 48
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).